Paige Holst
Amgen
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Paige Holst.
Cell | 1996
Shuqian Jing; Duanzhi Wen; Yanbin Yu; Paige Holst; Yi Luo; Mei Fang; Rami Tamir; Laarni Antonio; Zheng Hu; Rod Cupples; Jean-Claude Louis; Sylvia Hu; Bruce W. Altrock; Gary M. Fox
We report the expression cloning and characterization of GDNFR-alpha, a novel glycosylphosphatidylinositol-linked cell surface receptor for glial cell line-derived neurotrophic factor (GDNF). GDNFR-alpha binds GDNF specifically and mediates activation of the Ret protein-tyrosine kinase (PTK). Treatment of Neuro-2a cells expressing GDNFR-alpha with GDNF rapidly stimulates Ret autophosphorylation. Ret is also activated by treatment with a combination of GDNF and soluble GDNFR-alpha in cells lacking GDNFR-alpha, and this effect is blocked by a soluble Ret-Fc fusion protein. Ret activation by GDNF was also observed in cultured embryonic rat spinal cord motor neurons, a cell type that responds to GDNF in vivo. A model for the stepwise formation of a GDNF signal-transducing complex including GDNF, GDNFR-alpha, and the Ret PTK is proposed.
Journal of Biological Chemistry | 1997
Shuqian Jing; Yanbin Yu; Mei Fang; Zheng Hu; Paige Holst; Thomas C. Boone; John M. Delaney; Henry Schultz; Renping Zhou; Gary M. Fox
The receptor for glial cell line-derived neurotrophic factor (GDNF) consists of GFRα-1 and Ret. Neurturin is a GDNF-related neurotrophin whose receptor is presently unknown. Here we report that neurturin can bind to either GFRα-1 or GFRα-2, a novel receptor related to GFRα-1. Both GFRα-1 and GFRα-2 mediate neurturin-induced Ret phosphorylation. GDNF can also bind to either GFRα-1 or GFRα-2, and activate Ret in the presence of either binding receptor. Although both ligands interact with both receptors, cells expressing GFRα-1 bind GDNF more efficiently than neurturin, while cells expressing GFRα-2 bind neurturin preferentially. Cross-linking and Ret activation data also suggest that while there is cross-talk, GFRα-1 is the primary receptor for GDNF and GFRα-2 exhibits a preference for neurturin. We have also cloned a cDNA that apparently codes for a third member of the GFRα receptor family. This putative receptor, designated GFRα-3, is closely related in amino acid sequence and is nearly identical in the spacing of its cysteine residues to both GFRα-1 and GFRα-2. Analysis of the tissue distribution of GFRα-1, GFRα-2, GFRα-3, and Ret by Northern blot reveals overlapping but distinct patterns of expression. Consistent with a role in GDNF function, the GFRαs and Ret are expressed in many of the same tissues, suggesting that GFRαs mediate the action of GDNF family ligands in vivo.
Journal of Protein Chemistry | 1995
Tsutomu Arakawa; Paige Holst; Linda O. Narhi; John S. Philo; Jie Wen; Steven J. Prestrelski; Xiaotian Zhu; Douglas C. Rees; Gary M. Fox
High-affinity binding of basic fibroblast growth factor (bFGF) to the tyrosine kinase receptor requires cell-surface heparan sulfate proteoglycan or exogenous addition of heparin. The crystal structure of bFGF shows Arg40 and 45 on the surface opposite to the heparin-binding region, suggesting that these charged residues may be involved in the receptor binding. Therefore, these amino acids were mutated to aspartic acid separately or simultaneously, and also a simultaneous mutation to glutamic acid was introduced. These mutants displayed a mitogenic activity decreased greater than tenfold compared to the wild-type protein. Addition of heparin had no effect on the activity, while these mutants showed heparin-binding characteristics resembling those of the native sequence protein. The mutants exhibited decreased stability compared to the native sequence protein. Gradual changes in conformation were observed by circular dichroic and infrared spectroscopy. Heparin chromatography also showed the presence of denatured form for these mutants. However, in the presence of multivalent anions such as citrate, sucrose octasulfate, and heparin, the conformation of the mutants resembled that of the wild-type protein, as revealed by X-ray crystallography and circular dichroism spectra of the mutant with a Arg40 → Asp substitution.
Nature | 1994
Timothy D. Bartley; Robert W. Hunt; Andrew A. Welcher; William J. Boyle; Vann P. Parker; Richard A. Lindberg; Hsieng S. Lu; Anne Colombero; Robin Elliott; Brenda Guthrie; Paige Holst; James D. Skrine; Robert Toso; Ming Zhang; Elsa Fernandez; Geraldine Trail; Brian Varnum; Yosef Yarden; Tony Hunter; Gary M. Fox
Proceedings of the National Academy of Sciences of the United States of America | 2006
Yongliang Zhang; Yeonseok Chung; Caroline Bishop; Betsy Daugherty; Hilary T. Chute; Paige Holst; Carole Kurahara; Fred D. Lott; Ning Sun; Andrew A. Welcher; Chen Dong
Biochemistry | 1993
Linda O. Narhi; Qing Xin Hua; Tsutomu Arakawa; G. Michael Fox; Larry B. Tsai; Robert Rosenfeld; Paige Holst; James A. Miller; Michael A. Weiss
Protein Engineering | 1993
Tsutomu Arakawa; Thomas P. Horan; Linda O. Narhi; Douglas C. Rees; Susan G. Schiffer; Paige Holst; Steven J. Prestrelski; Larry B. Tsai; Gary M. Fox
Archive | 2004
Gary M. Fox; John K. Sullivan; Paige Holst; Steven Kiyoshi Yoshinaga
Archive | 1996
Shao-Ling Jing; Duanzhi Wen; Yun Yu; Paige Holst; Yi Luo; Minggang Fang; Rami Tamir; Laarni Antonio; Zhaoyong Hu; Rod Cupples; Jean-Claude Louis; Shen Hu; Bruce W. Altrock; Gerald M. Fox
Archive | 2001
Gary M. Fox; John K. Sullivan; Paige Holst; Steven Kiyoshi Yoshinaga